Transglutaminase 2 as a novel target in chronic kidney disease – Methods, mechanisms and pharmacological inhibition-Reference-Cited by-同舟云学术

Transglutaminase 2 as a novel target in chronic kidney disease – Methods, mechanisms and pharmacological inhibition

Published:2021-06 Issue: Volume:222 Page:107787
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Prat-Duran Judit,Pinilla Estéfano,Nørregaard Rikke,Simonsen Ulf,Buus Niels Henrik

Funder

Aarhus Universitets Forskningsfond

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference184 articles.

1. TG2-PP2A-MMP9 axis is involved in CD89 shedding and affects the generation of pathogenic IgA1- SCD89 complexes in IgA nephropathy;Abbad;Kidney Disease,2018

2. Transglutaminase-2: Evolution from pedestrian protein to a promising therapeutic target;Agnihotri;Amino Acids,2017

3. Diet-induced obesity promotes kidney endothelial stiffening and fibrosis dependent on the endothelial mineralocorticoid receptor;Aroor;Hypertension,2019

4. Inhibition of thrombin-activated fibrinolysis inhibitor increases survival in experimental kidney fibrosis;Atkinson;Journal of the American Society of Nephrology,2015

5. Imidazolium-based warheads strongly influence activity of water-soluble peptidic transglutaminase inhibitors;Badarau;European Journal of Medicinal Chemistry,2013

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of a liquid chromatography-triple quadrupole mass spectrometry method for the determination of isopeptide ε-(γ-glutamyl) lysine in human urine as biomarker for transglutaminase 2 cross-linked proteins;Journal of Chromatography A;2023-06

2. Allosteric Activation of Transglutaminase 2 via Inducing an “Open” Conformation for Osteoblast Differentiation;Advanced Science;2023-04-23

3. Diabetic endothelial microangiopathy and pulmonary dysfunction;Frontiers in Endocrinology;2023-03-21

4. Age-Related Changes in Extracellular Matrix;Biochemistry (Moscow);2022-12

5. Metformin prevents hypoxia‐induced podocyte injury by regulating the ZEB2 / TG2 axis;Nephrology;2022-10-17